Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Authors: Sergei Iugai, Armando Sardi, Teresa Diaz-Montes, Mary Caitlin King, Vladislav Kovalik, Luis Felipe Falla-Zuniga, Kseniia Uzhegova, Panayotis Ledakis, Carol Nieroda, Vadim Gushchin

Source: Gynecologic Oncology Reports, Vol 58, Iss , Pp 101705- (2025)

Subject Terms: Ovarian cancer, Adjuvant chemotherapy, Time to Chemotherapy, Treatment Delays, CRS/HIPEC, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S235257892500030X; https://doaj.org/toc/2352-5789

Access URL: https://doaj.org/article/a1be2cde07774fea90592435e5b52e0e

Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06)

Authors: Misato Masuyama, Norikazu Masuda, Hidetoshi Kawaguchi, Yutaka Yamamoto, Shigehira Saji, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Shoichiro Ohtani, Nobuaki Sato, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Toshinari Yamashita, Daisuke Yotsumoto, Masakazu Toi, Shinji Ohno

Source: Cancer Medicine, Vol 12, Iss 17, Pp 17718-17730 (2023)

Subject Terms: fulvestrant, HER2‐positive advanced or metastatic breast cancer, real‐world evidence, time to chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/caeec8fc425642ad8dfd47e91b38c921

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer

Authors: Yuchong Yang, Yao Lu, Hui Tan, Ming Bai, Xia Wang, Shaohua Ge, Tao Ning, Le Zhang, Jingjing Duan, Yansha Sun, Rui Liu, Hongli Li, Yi Ba, Ting Deng

Source: BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)

Subject Terms: Adjuvant chemotherapy, Colorectal cancer, Time to chemotherapy, Prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/cab21a1da0fb4981b7f40882e17f93c4

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Study indicates timing of chemotherapy may improve treatment for glioblastoma

Source: Xinhua News Agency, April 1, 2021, 2pp

Love and Laughter in the Time of Chemotherapy.

Authors: Sinaee, Bardia

Source: Quill & Quire; Oct2017, Vol. 83 Issue 8, p35-35, 1/2p, 1 Color Photograph